2009-12-31 14:04:44 -

KING OF PRUSSIA, PA -- (Marketwire) -- 12/31/09 -- Emergent Health Corp. (PINKSHEETS: EMGE) (PINKSHEETS: EMEG) Emergent (the "Company") is pleased to announce its forward stock split of 11 shares for each 10 shares owned is effective for shareholders of record today 12/31/09. All fractional shares will be rounded off to the next whole number.



This action has resulted in a symbol change for the Company to EMEG as well as a new CUSIP Number 29100Q 308.



To receive the new shares, all shareholders must submit their current certificate with a check for $15 for issuance of a certificate for the new shares, to Olde Monmouth Stock Transfer Co., Inc. located at 200 Memorial Parkway, Atlantic Highlands, NJ 07716. If your certificates are held in a brokerage account and you receive statements from them, you do not need to do anything, as the transaction will be handled directly.



The Company continues to be optimistic about its prospects for 2010 and amended its Bylaws to expand the Board of Directors to 9 to facilitate growth.



About Emergent Health Corp.



Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.



Sign up for Free Newsletter Updates here: emergenthealth.com :


This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.



This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Contact:

Emergent Health Corp.
20104 Valley Forge Circle
King of Prussia, PA 19406
Investor Relations
866-427-6143